Skip to main content
  • 7 Nikola Pašić Sq., 4th Fl., 11000 Belgrade
  • info@smj.rs

logo LKS

Review article

Bone transplantation in orthopaedic surgery

Dejan Aleksandrić1, Lazar Mičeta1,2, Želimir Jovanović1, Jovana Grupković3, Uroš Dabetić3, Boris Vukomanović1,2
  • Institute for Orthopedics Banjica, Belgrade, Serbia
  • University of Belgrade, Faculty of Medicine, Belgrade, Serbia
  • University Clinical Center of Serbia, Clinic for Orthopedic Surgery and Traumatology, Belgrade, Serbia

ABSTRACT

Osteons are the basic units of bone tissue. Four types of bone cells are responsible for building the bone matrix, maintaining it and remodeling the bone. Those are osteoprogenitor cells, osteoblasts, osteocytes, and osteoclasts. The main role of the bone is in the construction of the skeleton that provides support and enables the maintenance of a constant body shape and movement, which is achieved by a complex system of levers influenced by muscle forces at the attachment points.

A fracture leads to the process of inflammation, healing and, remodeling that can restore the injured bone to its original state. Nowadays, we are more and more often faced with defects of different size and etiology, which increase the need for bone transplantation. This procedure involves a surgical technique that places a new bone or a suitable substitute between or around the fractured fragments or in the area of the defect to promote bone healing.

Bone transplantation is possible because bone tissue, unlike most other tissues, has the ability to fully regenerate if it is provided with adequate conditions and the space in which it will grow. The basic biological mechanisms that justify and explain the principle and utilization of bone grafting are osteoconduction, osteoinduction, and osteogenesis, but the idea of osteopromotion is also worth mentioning.

Autografts represent the “gold standard”, but due to an increased need allografts from bone banks are primarily used nowadays, while the development of synthetic replacements is the primary research interest, especially the development of the form which could be applied with the use of minimally invasive techniques.


INTRODUCTION

Modern orthopedics is more and more frequently faced with the problem of treating bone defects of varying size and etiology. These defects occur in several ways and can be found as defects in various tumor-like lesions, after resection of parts of bone due to benign or malignant tumors, and as a consequence of traumatic bone loss, i.e., extensive resections in post-traumatic osteomyelitis. The main goal in the treatment of these conditions is to preserve extremities and to establish the highest possible level of functionality [1].

Different methods of treating bone defects have been presented in literature, bone transplantation being one of the best-known and most frequently applied ones [2]. Due to its characteristics, bone tissue is very suitable for transplantation, so the fact that this tissue is the second most frequently transplanted in the USA comes as no surprise [3]. With the development of disciplines that increase the safety and success of treatment (primarily the prevention of communicable diseases and the improvement of tissue compatibility), this method becomes particularly important, especially if we know that alternative methods (the bone transport technique using the Ilizarov method, alloplasty) have their limitations, such as not being applicable to all segments of the skeleton and not being adequate for treating younger patients [4].

Bone transplantation is a surgical procedure which involves placing a new bone or other material between or around the fragments of the broken bone or in the area of the defect with the aim of supporting its healing or regeneration. A missing bone is replaced by a bone graft using material from the very patient’s body or an allograft, but also an artificial, synthetic or natural bone substitute [5]. It is used in treating fractures which are complex, pose a significant risk to the patient’s life or have failed to heal properly [6]. It is also used with the aim of compensating for bone defects caused by congenital deformities, traumatic injuries, or resection of parts of bone due to various types of tumor or bone infections. It is important to mention that apart from orthopedic surgery, bone transplantation methods are used in neurosurgery, dentistry, and oral and maxillofacial surgery [7].

THE BIOLOGY OF BONE TISSUE

Bone tissue is a specialized connective tissue consisted of cells and extracellular matrix. A specific structure of the extracellular matrix, which contains a high percentage of minerals, provides bone tissue with exquisite firmness and hardness. The matrix is primarily composed of collagen, which forms its organic part, and the inorganic part made of crystals similar to hydroxyapatite which, in addition to calcium and phosphate, also contains deposits of carbonate, sodium citrate and magnesium [8],[9]. The main role of the bone is in the construction of the skeleton that provides support, and enables the maintenance of a constant body shape and movement, which is achieved by a complex system of levers influenced by muscle forces at the attachment points [7],[9],[10].

There are four types of bone cells situated inside and around this matrix. These four types are together responsible for building the bone matrix, maintaining it, and remodeling bone if necessary. The four types of cells are the following: (1) osteoprogenitor cells that line bone surfaces and have the ability of differentiating into osteoblasts; (2) osteoblasts that make up the bone matrix; (3) osteocytes, mature bone cells surrounded by bone tissue, which participate in signal pathways of bone homeostasis; and (4) osteoclasts, cells that degrade bone and remove bone tissue [7],[10],[11],[12],[13].

BONE TRANSPLANTATION AND BIOLOGICAL MECHANISMS

Bone transplantation is possible because bone tissue, unlike most other tissues, is capable of regenerating completely if it is provided with the space to grow into. As the original bone grows, it will eventually completely replace the transplanted material resulting in a fully integrated piece of new bone. The basic biological principles that justify and explain the principle of functioning and the use of bone transplantation are osteoconduction, osteoinduction, and osteogenesis, but osteopromotion is also worth discussing.

Osteoconduction is the ability of a bone graft to serve as a scaffold for the ingrowth of blood vessels and the new bone originating from stem cells [14]. Osteoblasts from the edges of the defect where the graft is placed use the material as the basis onto which it will spread creating a new bone. The basic condition a bone graft needs to have is to possess the characteristic of osteoconductivity [3],[15],[16].

Osteoinduction involves stimulating osteoprogenitory cells to differentiate into osteoblasts which then initiate the formation of a new bone. The most frequently examined osteoinductive cell mediators are bone morphogenetic proteins (BMPs). Bone graft which is both osteoconductive and osteoinductive will not only serve as a scaffold for the existing osteoblasts, but it will also initiate the formation of new osteoblasts, theoretically leading to a faster integration of the graft [3],[15],[16].

Osteopromotion implies an increase in osteoinductivity without possessing specific osteoinductive characteristics. For example, certain matrix derivatives ead to increased osteoinductive activity of demineralized freeze-dried bone allografts, but they will not stimulate de novo bone growth [3],[15],[16].

Osteogenesis is the ability of cellular elements within a graft which survived the transplantation to form a new bone. It occurs when vital osteoblasts derived from the bone graft contribute to the formation of new bone along with bone growth produced by other two mechanisms [3],[15],[16].

THE CHOICE OF GRAFT

Cortical bone grafts are primarily used for structural support, whereas cancellous grafts are used for the purpose of osteogenesis [5]. Structural support and osteogenesis can be combined as well, which is one of the main advantages of using bone grafts. However, it must be mentioned that these two factors are variable depending on the bone structure [17].

Most of the cellular elements of grafts (especially the cortical ones) are dying out and are gradually replaced by overgrowth where the graft essentially represents a scaffolding structure for the formation of new bone. In case of tough cortical bone, this replacement process is significantly slower than in cancellous grafts. Although cancellous bone possesses a greater power of osteogenesis, it is not tough enough to provide efficient structural support. In the situation when the surgeon has to choose a graft or a combination of grafts, they must always keep in mind these two fundamental differences in bone structure. When the graft unites with the recipient bone and when it gets strong enough to allow unhindered use of that part of the body, remodeling of bone structure occurs in accordance with functional requirements [14].

The use of bone grafts is wide and they can be used (1) to fill bone cavities and defects caused by various pathological processes, such as cysts, benign and malignant tumors in the first place, (2) to bridge joints and provide arthrodesis, (3) to bridge large defects and provide the continuity of long bones, (4) to provide bone blocks for limiting the range of motion of joints, (5) to achieve healing in pseudoarthrosis, (6) to promote healing and fill the defect areas in delayed healing, impaired healing, fresh fractures, or osteotomy [14],[17],[18].

In autologous or autogenous bone transplantation the donor and the transplant recipient are the same person. A part of bone can be taken from nonessential bones, such as the wing of ilium, the fibula, the tibia, or from the mandibular symphysis or the mandibular coronoid process, which is more often done in the field of oral and maxillofacial surgery [3],[18],[19].

GRAFT VASCULARIZATION

Each bone needs to be supplied with blood at the transplant site. Depending on the transplantation site and the size of the graft, additional vascularization may be necessary. It is important to distinguish between non-vascularized bone grafts, which are transferred to the donor site as free parts of the bone without associated vascularization, and vascularized bone elements, which are transferred to the recipient site connected to blood vessels. Vascularized bone grafts can be free when the associated part of periosteum and the corresponding blood vessel are extracted together with the bone element, and a vascular anastomosis of the associated blood vessel is performed at the recipient site [20],[21],[22]. In case of pedicled vascularized bone grafts, there is a transposition of bone element which remains linked to its neurovascular pedicle that continues to feed it at the recipient site [14]. Pedicled bone grafts are the only ones with preserved vascularization and innervation stem cells [21],[22],[23]. They actively participate in reparative regeneration and biological stimulation of osteogenesis. They are vital and resistant to infection. However, the application of pedicled bone grafts is limited, they require an advanced microvascular technique and there is the problem of donor site morbidity. For this reason, osteoperiosteal decortication at the ends of the fragments is more and more often applied [23],[24].

AUTOLOGOUS TRANSPLANTATION

The method of free bone autoplasty has been widely used. The advantage of this method is that a graft of required proportions can be easily taken from many different parts of the skeleton. Apart from this, the surgical procedure itself is simple. A free bone graft is compatible with the recipient’s organism and becomes an active stimulator of reparative osteogenesis. It is quickly rebuilt and filled with new tissue formed from stem cells. [23] When applying this type of graft, autogenous bone is the most preferred choice because of the lowest risk of graft rejection. As presented in Table 1, such a graft is osteoconductive, osteoinductive, and it leads to osteogenesis.

Table 1. Comparative presentation of the characteristics of different bone grafts

Table 1. Comparative presentation of the characteristics of different bone grafts

Autologous bone grafting can also be performed without a solid bone structure, for example by using bone scraped from the wing of ilium or the removed femoral head. In this case, osteoinduction and osteogenesis occur, whereas there is no osteoconduction due to the absence of a solid bone structure.

The negative aspect of autologous transplantation is the fact that harvesting a bone autograft is still an additional surgical procedure which is difficult for patients and which means an additional surgical incision that may be a potential site of postoperative pain and complications and which is sometimes even impossible to perform because of comorbidities [3],[25],[26],[27]. Apart from this, it should be noted that there are limits concerning the size of autograft that can be safely harvested from a patient, whereas the amount of allograft that can be implanted is practically unlimited.

With the development in the field of surgery, autoplasty can no longer meet the growing needs of osteoplastic material. This explains the constant striving to find the plastic material that would replace bone autografts. Through experimental and clinical work, it has been found that in low temperatures bone tissue harvested from a donor has a preserved morphological structure and biological activity even after some time. Bone allografts are slowly resorbed and replaced by new bone tissue [23].

ALLOGRAFTS AND XENOGRAFTS

An allogenic bone graft or allograft is also a graft obtained from the human organism, but is harvested from another person, not the patient himself/herself. Before bone banks, allografts were used only in cases when autologous grafts were unavailable or when it was impossible to use them. In children, the usual donor sites do not provide enough cortical bone for bridging the defect or they do not contain enough cancellous bone to fill large cavities or cysts. The risk of injuring the physis must also be taken into consideration. Grafts for children are usually harvested from their parents. Large structural allografts have been successfully used for years in revision joint replacement, periprosthetic fractures of long bones, and reconstruction after tumor resection surgery [5],[28],[29],[30]. Recently there have been attempts at using osteochondral allografts in treating osteonecrosis of the distal femur [14],[31]

Bone allografts may refer to (1) fresh or fresh-frozen bone, (2) freeze-dried bone allograft (FDBA), or (3) demineralized freeze-dried bone allograft (DFDBA). [14],[29],[32].

Having in mind the shortcomings of autografts and allografts, at the beginning of bone transplantation an attempt was made to use heterogeneous bones, i.e., xenografts – animal bones (most often beef bones), but unsatisfactory results were almost always obtained. The material more or less retained its original form, acting as an internal wedge, but it did not stimulate bone genesis and it often caused unwanted immune foreign body reaction [14],[33].

SYNTHETIC GRAFTS

There has been an increasing interest for synthetic bone graft materials. At the moment, several materials are either used or clinically tested. Artificial bone can be made from substances such as calcium phosphates (e.g.,. hydroxyapatite, tricalcium phosphate, or their combination – calcium phosphate cements), bioactive glass, and calcium sulphate which are all biologically active to a certain extent depending on their solubility in physiological environment [30],[34],[35],[36]. These materials can be impregnated with growth factors, ions such as strontium or they can be mixed with bone marrow aspirate with the aim of increasing their biological activity.

CONCLUSION

Autologous cancellous and cortical grafts still represent the gold standard all other grafts are compared with [3],[14]. However, we must not ignore the fact that with synthetic grafts the risk of infection and rejection is significantly lower, while their mechanical characteristics are in line with bone characteristics.

  • Conflict of interest:
    None declared.

Informations

Volume 4 No 2

June 2023

Pages 125-132
  • Keywords:
    bone graft, bone defects, osteoconduction, osteoinduction
  • Received:
    27 November 2022
  • Revised:
    19 December 2022
  • Accepted:
    13 February 2023
  • Online first:
    25 May 2023
  • DOI:
  • Cite this article:
    Aleksandrić D, Mičeta L, Jovanović Ž, Grupković J, Dabetić U, Vukomanović B. Bone transplantation in orthopaedic surgery. Serbian Journal of the Medical Chamber. 2023;4(2):125-32. doi: 10.5937/smclk4-41419
Corresponding author

Jovana Grupković
Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Serbia
2 Pasterova Street, 11000 Belgrade, Serbia
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


  • 1. Chiodo CP, Hahne J, Wilson MG, Glowacki J. Histological differences in iliac and tibial bone graft. Foot Ankle Int. 2010 May;31(5):418-22. doi: 10.3113/ FAI.2010.0418. [CROSSREF]

    2. Bezstarosti H, Metsemakers WJ, van Lieshout EMM, Voskamp LW, Kortram K, McNally MA, et al. Management of critical-sized bone defects in the treatment of fracture-related infection: a systematic review and pooled analysis. Arch Orthop Trauma Surg. 2021;141(7):1215-30. doi: 10.1007/s00402-020-03525-0. [CROSSREF]

    3. Schmidt AH. Autologous bone graft: Is it still the gold standard? Injury. 2021;52 Suppl 2:S18-S22. doi: 10.1016/j.injury.2021.01.043. [CROSSREF]

    4. Jahn K, Braunstein V, Furlong PI, Simpson AE, Richards RG, Stoddart MJ. A rapid method for the generation of uniform acellular bone explants: a technical note. J Orthop Surg Res. 2010 May 10;5(1):32. doi: 10.1186/1749-799X-5-32. [CROSSREF]

    5. Baldwin P, Li DJ, Auston DA, Mir HS, Yoon RS, Koval KJ. Autograft, Allograft, and Bone Graft Substitutes: Clinical Evidence and Indications for Use in the Setting of Orthopaedic Trauma Surgery. J Orthop Trauma. 2019;33(4):203-13. doi: 10.1097/BOT.0000000000001420. [CROSSREF]

    6. Archunan MW, Petronis S. Bone Grafts in Trauma and Orthopaedics. Cureus. 2021;13(9):e17705. Published 2021 Sep 4. doi: 10.7759/cureus.17705. [CROSSREF]

    7. Cha HS, Kim JW, Hwang JH, Ahn KM. Frequency of bone graft in implant surgery. Maxillofac Plast Reconstr Surg. 2016;38(1):19. Published 2016 Mar 31. doi: 10.1186/s40902-016-0064-2. [CROSSREF]

    8. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int. 2015;2015:421746. doi: 10.1155/2015/421746. [CROSSREF]

    9. Vukašinovic et al. Opšta ortopedija. IOHB "Banjica", Beograd. 2002.

    10. Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat Rev Mol Cell Biol. 2020;21(11):696-711. doi: 10.1038/s41580- 020-00279-w. [CROSSREF]

    11. Zaidi M, Yuen T, Sun L, Rosen CJ. Regulation of Skeletal Homeostasis. Endocr Rev. 2018;39(5):701-18. doi: 10.1210/er.2018-00050. [CROSSREF]

    12. Donsante S, Palmisano B, Serafini M, Robey PG, Corsi A, Riminucci M. From Stem Cells to Bone-Forming Cells. Int J Mol Sci. 2021;22(8):3989. Published 2021 Apr 13. doi: 10.3390/ijms22083989. [CROSSREF]

    13. Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99-107. doi: 10.1080/03008207.2017.1290085. [CROSSREF]

    14. Azar FM, Beaty JH, Canale ST, editors. Campbell’s Operative Orthopaedics. 13th ed. Philadelphia: Elsevier Inc; 2017

    15. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350. [CROSSREF]

    16. Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg. 2005;13(1):77-86. PMID: 15712985 [HTTP]

    17. Takaso M, Nakazawa T, Imura T, Ueno M, Saito W, Shintani R, et al. Surgical treatment of scoliosis using allograft bone from a regional bone bank. Arch Orthop Trauma Surg. 2010 May 15. doi: 10.1007/s00402-010-1111-6. [CROSSREF]

    18. Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D. Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res. 2010;132:15-30. PMID: 20693585

    19. Haugen HJ, Lyngstadaas SP, Rossi F, Perale G. Bone grafts: which is the ideal biomaterial? J Clin Periodontol. 2019;46 Suppl 21:92-102. doi: 10.1111/ jcpe.13058. [CROSSREF]

    20. Soucacos PN, Dailiana Z, Beris AE, Johnson EO. Vascularised bone grafts for the management of non-union. Injury 2006; 37S:S41. doi: 10.1016/j.injury.2006.02.040. [CROSSREF]

    21. Bumbasirevic M, Stevanovic M, Bumbasirevic V, Lesic A, Atkinson HD. Free vascularised fibular grafts in orthopaedics. Int Orthop. 2014;38(6):1277-82. doi: 10.1007/s00264-014-2281-6. [CROSSREF]

    22. Petrella G, Tosi D, Pantaleoni F, Adani R. Vascularized bone grafts for post-traumatic defects in the upper extremity. Arch Plast Surg. 2021;48(1):84-90 doi: 10.5999/aps.2020.00969. [CROSSREF]

    23. Vukašinović et al. Specijalna ortopedija. IOHB "Banjica", Beograd. 2004.

    24. Cho Y, Byun YS, Suh JD, Yoo J. Osteoperiosteal Decortication and Autogenous Cancellous Bone Graft Combined with Bridge Plating for Non-hypertrophic Diaphyseal Nonunion. Clin Orthop Surg. 2021;13(3):301-6. doi: 10.4055/ cios20227. [CROSSREF]

    25. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989;3(3):192-5. doi: 10.1097/00005131-198909000-00002. [CROSSREF]

    26. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am. 2002;84(5):716-20. doi: 10.2106/00004623-200205000-00003. [CROSSREF]

    27. Suda AJ, Schamberger CT, Viergutz T. Donor site complications following anterior iliac crest bone graft for treatment of distal radius fractures. Arch Orthop Trauma Surg. 2019;139(3):423-8. doi: 10.1007/s00402-018-3098-3. [CROSSREF]

    28. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350. [CROSSREF]

    29. Brink O. The choice between allograft or demineralized bone matrix is not unambiguous in trauma surgery. Injury. 2021;52 Suppl 2:S23-S28. doi: 10.1016/j.injury.2020.11.013. [CROSSREF]

    30. Gillman CE, Jayasuriya AC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C Mater Biol Appl. 2021;130:112466. doi: 10.1016/j.msec.2021.112466. [CROSSREF]

    31. Roberti Di Sarsisa T, Fiore M, Coco V, et al. Fresh Osteochondral Allograft Transplantation in Osteochondritis Dissecans in the Knee Joint. Life (Basel). 2021;11(11):1205. Published 2021 Nov 8. doi: 10.3390/life11111205. [CROSSREF]

    32. Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger JO. Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev. 2012;64(12):1063- 77. doi: 10.1016/j.addr.2012.06.008. [CROSSREF]

    33. Shibuya N, Jupiter DC. Bone graft substitute: allograft and xenograft. Clin Podiatr Med Surg. 2015;32(1):21-34. doi: 10.1016/j.cpm.2014.09.011. [CROSSREF]

    34. Dutta SR, Passi D, Singh P, Bhuibhar A. Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief review. Ir J Med Sci. 2015;184(1):101-6. doi: 10.1007/s11845-014-1199-8. [CROSSREF]

    35. Fernandez de Grado G, Keller L, Idoux-Gillet Y, et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018;9. Published 2018 Jun 4. doi: 10.1177/2041731418776819. [CROSSREF]

    36. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350.. [CROSSREF]


REFERENCES

1. Chiodo CP, Hahne J, Wilson MG, Glowacki J. Histological differences in iliac and tibial bone graft. Foot Ankle Int. 2010 May;31(5):418-22. doi: 10.3113/ FAI.2010.0418. [CROSSREF]

2. Bezstarosti H, Metsemakers WJ, van Lieshout EMM, Voskamp LW, Kortram K, McNally MA, et al. Management of critical-sized bone defects in the treatment of fracture-related infection: a systematic review and pooled analysis. Arch Orthop Trauma Surg. 2021;141(7):1215-30. doi: 10.1007/s00402-020-03525-0. [CROSSREF]

3. Schmidt AH. Autologous bone graft: Is it still the gold standard? Injury. 2021;52 Suppl 2:S18-S22. doi: 10.1016/j.injury.2021.01.043. [CROSSREF]

4. Jahn K, Braunstein V, Furlong PI, Simpson AE, Richards RG, Stoddart MJ. A rapid method for the generation of uniform acellular bone explants: a technical note. J Orthop Surg Res. 2010 May 10;5(1):32. doi: 10.1186/1749-799X-5-32. [CROSSREF]

5. Baldwin P, Li DJ, Auston DA, Mir HS, Yoon RS, Koval KJ. Autograft, Allograft, and Bone Graft Substitutes: Clinical Evidence and Indications for Use in the Setting of Orthopaedic Trauma Surgery. J Orthop Trauma. 2019;33(4):203-13. doi: 10.1097/BOT.0000000000001420. [CROSSREF]

6. Archunan MW, Petronis S. Bone Grafts in Trauma and Orthopaedics. Cureus. 2021;13(9):e17705. Published 2021 Sep 4. doi: 10.7759/cureus.17705. [CROSSREF]

7. Cha HS, Kim JW, Hwang JH, Ahn KM. Frequency of bone graft in implant surgery. Maxillofac Plast Reconstr Surg. 2016;38(1):19. Published 2016 Mar 31. doi: 10.1186/s40902-016-0064-2. [CROSSREF]

8. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int. 2015;2015:421746. doi: 10.1155/2015/421746. [CROSSREF]

9. Vukašinovic et al. Opšta ortopedija. IOHB "Banjica", Beograd. 2002.

10. Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat Rev Mol Cell Biol. 2020;21(11):696-711. doi: 10.1038/s41580- 020-00279-w. [CROSSREF]

11. Zaidi M, Yuen T, Sun L, Rosen CJ. Regulation of Skeletal Homeostasis. Endocr Rev. 2018;39(5):701-18. doi: 10.1210/er.2018-00050. [CROSSREF]

12. Donsante S, Palmisano B, Serafini M, Robey PG, Corsi A, Riminucci M. From Stem Cells to Bone-Forming Cells. Int J Mol Sci. 2021;22(8):3989. Published 2021 Apr 13. doi: 10.3390/ijms22083989. [CROSSREF]

13. Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99-107. doi: 10.1080/03008207.2017.1290085. [CROSSREF]

14. Azar FM, Beaty JH, Canale ST, editors. Campbell’s Operative Orthopaedics. 13th ed. Philadelphia: Elsevier Inc; 2017

15. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350. [CROSSREF]

16. Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg. 2005;13(1):77-86. PMID: 15712985 [HTTP]

17. Takaso M, Nakazawa T, Imura T, Ueno M, Saito W, Shintani R, et al. Surgical treatment of scoliosis using allograft bone from a regional bone bank. Arch Orthop Trauma Surg. 2010 May 15. doi: 10.1007/s00402-010-1111-6. [CROSSREF]

18. Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D. Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res. 2010;132:15-30. PMID: 20693585

19. Haugen HJ, Lyngstadaas SP, Rossi F, Perale G. Bone grafts: which is the ideal biomaterial? J Clin Periodontol. 2019;46 Suppl 21:92-102. doi: 10.1111/ jcpe.13058. [CROSSREF]

20. Soucacos PN, Dailiana Z, Beris AE, Johnson EO. Vascularised bone grafts for the management of non-union. Injury 2006; 37S:S41. doi: 10.1016/j.injury.2006.02.040. [CROSSREF]

21. Bumbasirevic M, Stevanovic M, Bumbasirevic V, Lesic A, Atkinson HD. Free vascularised fibular grafts in orthopaedics. Int Orthop. 2014;38(6):1277-82. doi: 10.1007/s00264-014-2281-6. [CROSSREF]

22. Petrella G, Tosi D, Pantaleoni F, Adani R. Vascularized bone grafts for post-traumatic defects in the upper extremity. Arch Plast Surg. 2021;48(1):84-90 doi: 10.5999/aps.2020.00969. [CROSSREF]

23. Vukašinović et al. Specijalna ortopedija. IOHB "Banjica", Beograd. 2004.

24. Cho Y, Byun YS, Suh JD, Yoo J. Osteoperiosteal Decortication and Autogenous Cancellous Bone Graft Combined with Bridge Plating for Non-hypertrophic Diaphyseal Nonunion. Clin Orthop Surg. 2021;13(3):301-6. doi: 10.4055/ cios20227. [CROSSREF]

25. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989;3(3):192-5. doi: 10.1097/00005131-198909000-00002. [CROSSREF]

26. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am. 2002;84(5):716-20. doi: 10.2106/00004623-200205000-00003. [CROSSREF]

27. Suda AJ, Schamberger CT, Viergutz T. Donor site complications following anterior iliac crest bone graft for treatment of distal radius fractures. Arch Orthop Trauma Surg. 2019;139(3):423-8. doi: 10.1007/s00402-018-3098-3. [CROSSREF]

28. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350. [CROSSREF]

29. Brink O. The choice between allograft or demineralized bone matrix is not unambiguous in trauma surgery. Injury. 2021;52 Suppl 2:S23-S28. doi: 10.1016/j.injury.2020.11.013. [CROSSREF]

30. Gillman CE, Jayasuriya AC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C Mater Biol Appl. 2021;130:112466. doi: 10.1016/j.msec.2021.112466. [CROSSREF]

31. Roberti Di Sarsisa T, Fiore M, Coco V, et al. Fresh Osteochondral Allograft Transplantation in Osteochondritis Dissecans in the Knee Joint. Life (Basel). 2021;11(11):1205. Published 2021 Nov 8. doi: 10.3390/life11111205. [CROSSREF]

32. Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger JO. Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev. 2012;64(12):1063- 77. doi: 10.1016/j.addr.2012.06.008. [CROSSREF]

33. Shibuya N, Jupiter DC. Bone graft substitute: allograft and xenograft. Clin Podiatr Med Surg. 2015;32(1):21-34. doi: 10.1016/j.cpm.2014.09.011. [CROSSREF]

34. Dutta SR, Passi D, Singh P, Bhuibhar A. Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief review. Ir J Med Sci. 2015;184(1):101-6. doi: 10.1007/s11845-014-1199-8. [CROSSREF]

35. Fernandez de Grado G, Keller L, Idoux-Gillet Y, et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018;9. Published 2018 Jun 4. doi: 10.1177/2041731418776819. [CROSSREF]

36. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350.. [CROSSREF]

1. Chiodo CP, Hahne J, Wilson MG, Glowacki J. Histological differences in iliac and tibial bone graft. Foot Ankle Int. 2010 May;31(5):418-22. doi: 10.3113/ FAI.2010.0418. [CROSSREF]

2. Bezstarosti H, Metsemakers WJ, van Lieshout EMM, Voskamp LW, Kortram K, McNally MA, et al. Management of critical-sized bone defects in the treatment of fracture-related infection: a systematic review and pooled analysis. Arch Orthop Trauma Surg. 2021;141(7):1215-30. doi: 10.1007/s00402-020-03525-0. [CROSSREF]

3. Schmidt AH. Autologous bone graft: Is it still the gold standard? Injury. 2021;52 Suppl 2:S18-S22. doi: 10.1016/j.injury.2021.01.043. [CROSSREF]

4. Jahn K, Braunstein V, Furlong PI, Simpson AE, Richards RG, Stoddart MJ. A rapid method for the generation of uniform acellular bone explants: a technical note. J Orthop Surg Res. 2010 May 10;5(1):32. doi: 10.1186/1749-799X-5-32. [CROSSREF]

5. Baldwin P, Li DJ, Auston DA, Mir HS, Yoon RS, Koval KJ. Autograft, Allograft, and Bone Graft Substitutes: Clinical Evidence and Indications for Use in the Setting of Orthopaedic Trauma Surgery. J Orthop Trauma. 2019;33(4):203-13. doi: 10.1097/BOT.0000000000001420. [CROSSREF]

6. Archunan MW, Petronis S. Bone Grafts in Trauma and Orthopaedics. Cureus. 2021;13(9):e17705. Published 2021 Sep 4. doi: 10.7759/cureus.17705. [CROSSREF]

7. Cha HS, Kim JW, Hwang JH, Ahn KM. Frequency of bone graft in implant surgery. Maxillofac Plast Reconstr Surg. 2016;38(1):19. Published 2016 Mar 31. doi: 10.1186/s40902-016-0064-2. [CROSSREF]

8. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int. 2015;2015:421746. doi: 10.1155/2015/421746. [CROSSREF]

9. Vukašinovic et al. Opšta ortopedija. IOHB "Banjica", Beograd. 2002.

10. Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat Rev Mol Cell Biol. 2020;21(11):696-711. doi: 10.1038/s41580- 020-00279-w. [CROSSREF]

11. Zaidi M, Yuen T, Sun L, Rosen CJ. Regulation of Skeletal Homeostasis. Endocr Rev. 2018;39(5):701-18. doi: 10.1210/er.2018-00050. [CROSSREF]

12. Donsante S, Palmisano B, Serafini M, Robey PG, Corsi A, Riminucci M. From Stem Cells to Bone-Forming Cells. Int J Mol Sci. 2021;22(8):3989. Published 2021 Apr 13. doi: 10.3390/ijms22083989. [CROSSREF]

13. Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99-107. doi: 10.1080/03008207.2017.1290085. [CROSSREF]

14. Azar FM, Beaty JH, Canale ST, editors. Campbell’s Operative Orthopaedics. 13th ed. Philadelphia: Elsevier Inc; 2017

15. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350. [CROSSREF]

16. Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg. 2005;13(1):77-86. PMID: 15712985 [HTTP]

17. Takaso M, Nakazawa T, Imura T, Ueno M, Saito W, Shintani R, et al. Surgical treatment of scoliosis using allograft bone from a regional bone bank. Arch Orthop Trauma Surg. 2010 May 15. doi: 10.1007/s00402-010-1111-6. [CROSSREF]

18. Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D. Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res. 2010;132:15-30. PMID: 20693585

19. Haugen HJ, Lyngstadaas SP, Rossi F, Perale G. Bone grafts: which is the ideal biomaterial? J Clin Periodontol. 2019;46 Suppl 21:92-102. doi: 10.1111/ jcpe.13058. [CROSSREF]

20. Soucacos PN, Dailiana Z, Beris AE, Johnson EO. Vascularised bone grafts for the management of non-union. Injury 2006; 37S:S41. doi: 10.1016/j.injury.2006.02.040. [CROSSREF]

21. Bumbasirevic M, Stevanovic M, Bumbasirevic V, Lesic A, Atkinson HD. Free vascularised fibular grafts in orthopaedics. Int Orthop. 2014;38(6):1277-82. doi: 10.1007/s00264-014-2281-6. [CROSSREF]

22. Petrella G, Tosi D, Pantaleoni F, Adani R. Vascularized bone grafts for post-traumatic defects in the upper extremity. Arch Plast Surg. 2021;48(1):84-90 doi: 10.5999/aps.2020.00969. [CROSSREF]

23. Vukašinović et al. Specijalna ortopedija. IOHB "Banjica", Beograd. 2004.

24. Cho Y, Byun YS, Suh JD, Yoo J. Osteoperiosteal Decortication and Autogenous Cancellous Bone Graft Combined with Bridge Plating for Non-hypertrophic Diaphyseal Nonunion. Clin Orthop Surg. 2021;13(3):301-6. doi: 10.4055/ cios20227. [CROSSREF]

25. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989;3(3):192-5. doi: 10.1097/00005131-198909000-00002. [CROSSREF]

26. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am. 2002;84(5):716-20. doi: 10.2106/00004623-200205000-00003. [CROSSREF]

27. Suda AJ, Schamberger CT, Viergutz T. Donor site complications following anterior iliac crest bone graft for treatment of distal radius fractures. Arch Orthop Trauma Surg. 2019;139(3):423-8. doi: 10.1007/s00402-018-3098-3. [CROSSREF]

28. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350. [CROSSREF]

29. Brink O. The choice between allograft or demineralized bone matrix is not unambiguous in trauma surgery. Injury. 2021;52 Suppl 2:S23-S28. doi: 10.1016/j.injury.2020.11.013. [CROSSREF]

30. Gillman CE, Jayasuriya AC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C Mater Biol Appl. 2021;130:112466. doi: 10.1016/j.msec.2021.112466. [CROSSREF]

31. Roberti Di Sarsisa T, Fiore M, Coco V, et al. Fresh Osteochondral Allograft Transplantation in Osteochondritis Dissecans in the Knee Joint. Life (Basel). 2021;11(11):1205. Published 2021 Nov 8. doi: 10.3390/life11111205. [CROSSREF]

32. Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger JO. Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev. 2012;64(12):1063- 77. doi: 10.1016/j.addr.2012.06.008. [CROSSREF]

33. Shibuya N, Jupiter DC. Bone graft substitute: allograft and xenograft. Clin Podiatr Med Surg. 2015;32(1):21-34. doi: 10.1016/j.cpm.2014.09.011. [CROSSREF]

34. Dutta SR, Passi D, Singh P, Bhuibhar A. Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief review. Ir J Med Sci. 2015;184(1):101-6. doi: 10.1007/s11845-014-1199-8. [CROSSREF]

35. Fernandez de Grado G, Keller L, Idoux-Gillet Y, et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018;9. Published 2018 Jun 4. doi: 10.1177/2041731418776819. [CROSSREF]

36. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016;98-B(1 Suppl A):6-9. doi: 10.1302/0301-620X.98B.36350.. [CROSSREF]


© All rights reserved. Medical Chamber of Serbia.

To top